☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Extension
Novartis Reports Results of Entresto (sacubitril/valsartan) in PIONEER-HF 4-Week Extension Study for Systolic Heart Failure
March 18, 2019
Lilly Announces an Extension to 2015 Research Collaboration deal with Dana Farber Cancer Institute
July 30, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.